 |
 |
|
|
|
| Aprepitant |
 |
| Aprepitant |
 |
| 170729-80-3 |
 |
A novel selective neurokinin-1 (NK-1) receptor antagonist. In vitro studies using human liver microsomes indicate that Aprepitant is metabolized primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19, and no metabolism by CYP2D6, CYP2C9, or CYP2
|
 |
English Name Aprepitant
CAS 170729-80-3
Molecular formula C23H21F7N4O3
Molecular weight 534.4266624
Categories Chiral Reagents
Heterocyclic
Intermediates & Fine Chemicals
Pharmaceuticals
Quality standard company standard
Assay 99%
Unit KG
Package 25 kilogram cardboard drum
Chemical Properties Off-White to Light Yellow Crystalline Solid
Usage A novel selective neurokinin-1 (NK-1) receptor antagonist. In vitro studies using human liver microsomes indicate that Aprepitant is metabolized primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19, and no metabolism by CYP2D6, CYP2C9, or CYP2
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
